Genetic testing company 23andMe agreed to pay $30 million for a class action that resulted from a major data breach in 2023. The company, which has struggled financially and unsuccessfully tried to go private earlier this year, was alleged to have not properly notified customers of the breach. This included ethnic groups that were singled out for having their data taken.
The UK Information Commissioner’s Office (ICO) confirmed LinkedIn will no longer use UK user data to train AI. The company confirmed it also won’t use data from the European Economic Area or Switzerland, at least “until further notice.” Elsewhere, users must make the change manually by going to their Data & Privacy setting and toggling “Off.”
Texas squared off with the US Department of Health and Human Services (HHS), and is looking to make it legal to chase down women’s medical records (think abortion) if they cross the state line. Currently, this is illegal because of the Biden administration privacy update to the Health Insurance Portability and Accountability Act (HIPAA). But, if this first-of-its-kind-vigilante-style Texas law were to go into effect, it would set a precedent for the dozen or so other states determined to take back abortion rights.
CDP mParticle is being acquired by ecommerce platform Rokt for a price of $300 million. It’s the third acquisition of a leading independent CDP in a little over one month, following Uniphore’s purchase of ActionIQ and Contentstack’s purchase of Lytics. All three buyers offer some type of customer-facing technology; apparently they’ve decided that adding real-time profiles from CDP will give them a competitive edge. (See this blog post for more analysis.)